Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted three Sangamo abstracts for presentation at ...

Kriya’s integrated R&D and manufacturing platform is designed to make gene therapies accessible for more common chronic diseasesASGCT ...

Scribe Therapeutics to highlight engineered CRISPR platform advances and lead cardiometabolic pipeline at ASGCT and EAS Congress 2026 ...

Presentations highlight AI-driven mRNA design process enabling up to 40-fold selectivity and 10-fold in vivo oncoselectivity ...

This presentation marks a critical step toward what KROMATID is building as the world's first genomic intelligence platform - ...

Dr. Hans-Peter Kiem, recent recipient of the American Society of Gene and Cell Therapy George Stamatoyannopoulos Mentorship ...

Computational and preclinical data support advancement of LTS-201 and LTS-101 programs into clinic later this yearLatus ...

SAN FRANCISCO, April 27, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology today announced the publication of its first peer-reviewed manuscript in Molecular Therapy Oncology, alongside upcoming ...

The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing. Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced ...

Next week, Los Angeles hosts what is likely to be the largest gene therapy conference in history as the American Society of Gene and Cell Therapy (ASGCT) arrives. More than 6,000 attendees are ...

Oral presentation will highlight new interim clinical data from the ongoing POLARIS studies; additional posters showcase broader platform capabilities -SOUTH SAN FRANCISCO, Calif.--(BUSINESS ...

SAN DIEGO--(BUSINESS WIRE)--Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be presenting preclinical data for its ...